These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37650886)

  • 1. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
    Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
    Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
    Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
    Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg (-)/HBsAb (-)/HBeAg (-)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B-cell lymphoma receiving rituximab based immunochemotherapy.
    Shui LP; Zhu Y; Duan XQ; Chen YT; Yang L; Tang XQ; Zhang HB; Xiao Q; Wang L; Liu L; Luo XH
    J Med Virol; 2023 Feb; 95(2):e28549. PubMed ID: 36734081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
    Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
    BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
    Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
    Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
    Chen KL; Chen J; Rao HL; Guo Y; Huang HQ; Zhang L; Shao JY; Lin TY; Jiang WQ; Zou DH; Hu LY; Wirian ML; Cai QQ
    Chin J Cancer; 2015 May; 34(5):225-34. PubMed ID: 26058465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
    Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
    Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
    Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.
    Attia KA; Eholié S; Messou E; Danel C; Polneau S; Chenal H; Toni T; Mbamy M; Seyler C; Wakasugi N; N'dri-Yoman T; Anglaret X
    World J Hepatol; 2012 Jul; 4(7):218-23. PubMed ID: 22855697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
    Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
    Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.
    Cheng CL; Huang SC; Chen JH; Wei CH; Fang WQ; Su TH; Yuan CT; Liu JH; Chuang MK; Tien HF
    Oncologist; 2020 Sep; 25(9):793-802. PubMed ID: 32275807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization.
    Kafeero HM; Ndagire D; Ocama P; Kato CD; Wampande E; Walusansa A; Kajumbula H; Kateete D; Sendagire H
    Sci Rep; 2022 May; 12(1):7425. PubMed ID: 35523938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
    Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
    Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C.
    Morrone A; Fiorilli V; Cinti L; Roberto P; Ferri AL; Visentini M; Pulsoni A; Spinelli FR; De Santis A; Antonelli G; Basili S; Tosti ME; Conti F; Casato M
    Front Immunol; 2024; 15():1411146. PubMed ID: 39055707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    Malamba SS; Muyinda H; Ogwang DM; Katamba A; Zamar DS; Jongbloed K; Sewankambo NK; Schechter MT; Spittal PM
    PLoS One; 2021; 16(5):e0251573. PubMed ID: 34043637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma.
    Mert D; Merdin A; Ceken S; Dal MS; Ertek M; Altuntas F
    J Cancer Res Ther; 2021; 17(4):951-955. PubMed ID: 34528547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
    Yamauchi N; Maruyama D; Choi I; Atsuta Y; Sakai R; Miyashita K; Moriuchi Y; Tsujimura H; Kubota N; Yamamoto G; Igarashi T; Izutsu K; Yoshida S; Kojima K; Uchida T; Inoue Y; Tsukamoto N; Ohtsuka E; Suzuki S; Inaguma Y; Ichikawa S; Gomyo H; Ushijima Y; Nosaka K; Kurata M; Tanaka Y; Ueda R; Mizokami M; Kusumoto S
    Cancer Sci; 2021 May; 112(5):1943-1954. PubMed ID: 33576088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
    Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
    Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.